Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury

Stem Cells and Development

Volumn 20, Issue 1, 2011, Pages 103-113

  Chen, Yuan ^a   Qian, Hui ^a   Zhu, Wei ^a   Zhang, Xu ^a   Yan, Yongmin ^a   Ye, Shengqin ^b   Peng, Xiujuan ^a   Li, Wei ^b   Xu, Wenrong ^a  

^a JIANGSU UNIVERSITY   (China)

^b Jiangsu Center for Stem Cell Engineering and Technology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CREATININE; CYCLINE; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; SCATTER FACTOR;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY CLAMP; ARTICLE; CAROTID ARTERY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HYPEREMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INHIBITION KINETICS; KIDNEY ISCHEMIA; KIDNEY TUBULE; MESENCHYMAL STEM CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION; KIDNEY; KIDNEY FUNCTION TESTS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TRANSDUCTION, GENETIC; UMBILICAL CORD;

ADENOVIRIDAE; ANIMALIA; RATTUS;

EID: 78650977193     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0495     Document Type: Article

References (35)

1. Qiao C, W Xu, W Zhu, J Hu, H Qian, Q Yin, R Jiang, Y Yan, F Mao, H Yang, X Wang and Y Chen. (2008). Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 32:8-15.
2. Gueler F, W Gwinner, A Schwarz and H Haller. (2004). Long-term effects of acute ischemia and reperfusion injury. Kidney Int 66:523-527.
3. Weight SC, PR Bell and ML Nicholson. (1996). Renal ischaemia-reperfusion injury. Br J Surg 83:162-170.
4. Daemen MA, C vant Veer, G Denecker, VH Heemskerk, TG Wolfs, M Clauss, P Vandenabeele and WA Buurman. (1999). Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541-549.
5. Palevsky PM. (2006). Epidemiology of acute renal failure: the tip of the iceberg. Clin J Am Soc Nephrol 1:6-7.
6. Boros P and CM Miller. (1995). Hepatocyte growth factor: a multifunctional cytokine. Lancet 345:293-295.
7. Miller SB, DR Martin, J Kissane and MR Hammerman. (1994). Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 266:F129-F134.
8. Joannidis M, K Spokes, T Nakamura, D Faletto and LG Cantley. (1994). Regional expression of hepatocyte growth factor=c-met in experimental renal hypertrophy and hyperplasia. Am J Physiol 267:F231-F236.
9. Herrera MB, B Bussolati, S Bruno, V Fonsato, GM Romanazzi and G Camussi. (2004). Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14:1035-1041.
10. Morigi M, M Introna, B Imberti, D Corna, M Abbate, C Rota, D Rottoli, A Benigni, N Perico, C Zoja, A Rambaldi, A Remuzzi and G Remuzzi. (2008). Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26:2075-2082.
11. Lange C, F Togel, H Ittrich, F Clayton, C Nolte-Ernsting, AR Zander and C Westenfelder. (2005). Administered mesenchymal stem cells enhance recovery from ischemia=reperfusioninduced acute renal failure in rats. Kidney Int 68:1613-1617. (Pubitemid 43169906)
12. Bian L, ZK Guo, HX Wang, JS Wang, H Wang, QF Li, YF Yang, FJ Xiao, CT Wu and LS Wang. (2009). In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. In Vivo 23:21-27.
13. Kim SM, JY Lim, SI Park, CH Jeong, JH Oh, M Jeong, W Oh, SH Park, YC Sung and SS Jeun. (2008). Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 68:9614-9623.
14. Lu Z, X Hu, C Zhu, D Wang, X Zheng and Q Liu. (2009). Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. J Neuroimmunol 206:58-69.
15. Wang HS, SC Hung, ST Peng, CC Huang, HM Wei, YJ Guo, YS Fu, MC Lai and CC Chen. (2004). Mesenchymal stem cells in the Whartons jelly of the human umbilical cord. Stem Cells 22:1330-1337.
16. Fu YS, YC Cheng, MY Lin, H Cheng, PM Chu, SC Chou, YH Shih, MH Ko and MS Sung. (2006). Conversion of human umbilical cord mesenchymal stem cells in Whartons jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24:115-124.
17. Weiss ML, S Medicetty, AR Bledsoe, RS Rachakatla, M Choi, S Merchav, Y Luo, MS Rao, G Velagaleti and D Troyer. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinsons disease. Stem Cells 24:781-792.
18. Sun JH, GJ Teng, SH Ju, ZL Ma, XL Mai and M Ma. (2008). MR tracking of magnetically labeledmesenchymal stemcells in rat kidneys with acute renal failure. Cell Transplant 17:279-290.
19. Herrera MB, B Bussolati, S Bruno, L Morando, G Mauriello-Romanazzi, F Sanavio, I Stamenkovic, L Biancone and G Camussi. (2007). Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 72:430-441.
20. Poulsom R. (2007). CD44 and hyaluronan help mesenchymal stem cells move to a neighborhood in need of regeneration. Kidney Int 72:389-390.
21. Valdes-Arzate A, A Luna, L Bucio, C Licona, DL Clemens, V Souza, E Hernandez, D Kershenobich, MC Gutierrez-Ruiz and LE Gomez-Quiroz. (2009). Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism. Free Radic Biol Med 47:424-430.
22. Xue F, Y Isaka, T Takahara, R Imamura, C Suzuki, N Ichimaru, P Michieli and S Takahara. (2007). HGF-MSP chimera protects kidneys from ischemia-reperfusion injury. Biochem Biophys Res Commun 363:451-456.
23. Schievenbusch S, I Strack,MScheffler, K Wennhold, JMaurer, R Nischt, HP Dienes andMOdenthal. (2009). Profiling of antifibrotic signaling by hepatocyte growth factor in renal fibroblasts. Biochem Biophys Res Commun 385:55-61.
24. Trapp T, G Kogler, A El-Khattouti, RV Sorg, M Besselmann, M Focking, CP Buhrle, I Trompeter, JC Fischer and P Wernet. (2008). Hepatocyte growth factor=c-MET axis-mediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury. J Biol Chem 283:32244-32253.
25. Zhu XY, XZ Zhang, L Xu, XY Zhong, Q Ding and YX Chen. (2009). Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue. Biochem Biophys Res Commun 379:1084-1090.
26. Guo Y, J He, J Wu, L Yang, S Dai, X Tan and L Liang. (2008). Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis. Arch Med Res 39:179-188.
27. Cao H, H Qian, W Xu, W Zhu, X Zhang, Y Chen, M Wang, Y Yan and Y Xie. (2010). Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia=reperfusioninduced acute renal failure in rats. Biotechnol Lett 32:725-732.
28. Giannopoulou M, C Dai, X Tan, X Wen, GK Michalopoulos and Y Liu. (2008). Hepatocyte growth factor exerts its antiinflammatory action by disrupting nuclear factor-kappaB signaling. Am J Pathol 173:30-41.
29. Franquesa M, M Riera, I Herrero-Fresneda, A Sola, G Hotter, N Lloberas, JM Cruzado, J Torras and JM Grinyo. (2009). Tubular epithelial cells transfected with hHGF counteracts monocyte chemotactic protein-1 up-regulation after hypoxia= reoxygenation insult. Transplant Proc 41:2069-2072.
30. Wang Y, F Hu, ZJ Wang, GX Wang, ZH Zhang, P Xie and SP Cui. (2008). Administration of bone marrow-derived stem cells suppresses cellular necrosis and apoptosis induced by reperfusion of ischaemic kidneys in rats. Chin Med J (Engl) 121:268-271.
31. Semedo P, CG Palasio, CD Oliveira, CQ Feitoza, GM Goncalves, MA Cenedeze, PM Wang, VP Teixeira, MA Reis, A Pacheco-Silva and NO Camara. (2009). Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int Immunopharmacol 9:677-682.
32. Dai C, J Yang and Y Liu. (2002). Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 13:411-422.
33. Zhang J, J Yang and Y Liu. (2008). Role of Bcl-xL Induction in HGF-mediated renal epithelial cell survival after oxidant stress. Int J Clin Exp Pathol 1:242-253.
34. Li-Juan B, L Bing, L Zhi, L Yang and L Ying-Jie. (2009). Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression. Pathol Res Pract 205:828-837.
35. Chen XH, S Minatoguchi, K Kosai, K Yuge, T Takahashi, M Arai, N Wang, Y Misao, C Lu, H Onogi, H Kobayashi, S Yasuda, M Ezaki, H Ushikoshi, G Takemura, T Fujiwara and H Fujiwara. (2007). In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. J Card Fail 13:874-883.